Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia

This publication has 21 references indexed in Scilit:

• Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
  Cancer Research, 2004
• HPV in cervix and vagina
  Sexually Transmitted Infections, 2004
• Disease-Stage Variance in Functional CD4+ T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 Epitopes
  Clinical Cancer Research, 2004
• Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer
  Reviews in Medical Virology, 2004
• POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
  International Journal of Cancer, 2004
• Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
  International Journal of Cancer, 2000
• Persistence of Human Papillomavirus Type 16 Infection Is Associated with Lack of Cytotoxic T Lymphocyte Response to the E6 Antigens
  The Journal of Infectious Diseases, 2000
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
  The Journal of Pathology, 1999
• HPV infections and immunosuppression
  Clinics in Dermatology, 1997
• Radical Hysterectomy for Stage IB1 vs IB2 Carcinoma of the Cervix: Does the New Staging System Predict Morbidity and Survival?
  Gynecologic Oncology, 1996